Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine

NCT01443663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

69

Enrollment

NIH

Sponsor class

Conditions

H5N1 Influenza

Interventions

BIOLOGICAL: H5N1 Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)